Advertisement
Discussion| Volume 9, ISSUE 3, P130-136, September 1999

Cytotoxic chemotherapy in the treatment of carcinoma of the uterine cervix

DOI:https://doi.org/10.1016/S0957-5847(99)90055-0
Cytotoxic chemotherapy in the treatment of carcinoma of the uterine cervix
Previous ArticleAdenocarcinoma of the cervix
Next ArticleSurgery for cervical cancer
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      There is a long history of interest in the use of chemotherapy in the treatment of cancer of the uterine cervix. Response rates in patients with chemotherapy-naive disease are in excess of 50% and this has encouraged investigators to use chemotherapy as neoadjuvant treatment, as a post-surgical adjuvant, concurrently with radiation, via regional infusion and in the treatment of recurrent and metastatic disease. Recent publications have shown a benefit for the use of concurrent chemoradiation in previously untreated patients, particularly in women with bulky stage I and 11 disease. Despite this, many questions regarding the use of chemotherapy in cervix cancer remain unanswered and these include optimal drug combinations, scheduling and timing.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Obstetrics, Gynaecology and Reproductive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Sardi J.
        • Sananes C.
        • Giaroli A.
        • et al.
        Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky squamous carcinoma of the cervix.
        Gynecol Oncol. 1993; 49: 156-165
        • Sardi J.
        • Sananes A.
        • Giaroli A.
        • et al.
        Neoadjuvant chemotherapy in cervical carcinoma stage IIb:a randomized controlled trial.
        International Journal of Gynaecological Cancer. 1998; 8: 441-450
        • Sundfor K.
        • Trope C.G.
        • Hogberg T.
        • et al.
        Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
        Cancer. 1996; 77: 2371-2378
        • Kumar L.
        • Kaushal R.
        • Nandy M.
        • et al.
        Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study.
        Gynecol Oncol. 1994; 54: 307-315
        • Souhami L.
        • Gil R.A.
        • Allan S.E.
        • et al.
        A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.
        J Clin Oncol. 1991; 9: 970-977
        • Tattersall M.H.
        • Lorvidhaya V.
        • Vootiprux V.
        • et al.
        Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian-Oceanian Clinical Oncology Association.
        J Clin Oncol. 1995; 13: 444-451
        • Lai C.H.
        • Lin T.S.
        • Soong Y.K.
        • Chen H.E.
        Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma.
        Gynecol Oncol. 1989; 35: 193-198
        • Killackey M.A.
        • Boardman L.
        • Carroll D.S.
        Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/lla cervical cancer.
        Gynecol Oncol. 1993; 49: 377-379
        • Tattersall M.H.
        • Ramirez C.
        • Coppleson M.
        A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases.
        Gynecol Oncol. 1992; 46: 176-181
        • Curtin J.P.
        • Hoskins W.J.
        • Venkatraman E.S.
        • et al.
        Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial.
        Gynecol Oncol. 1996; 61: 3-10
        • Morris M.
        • Eifel P.J.
        • Lu J.
        • et al.
        Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer.
        N Engl J Med. 1999; 340: 1137-1143
        • Rose P.G.
        • Bundy B.N.
        • Watkins E.B.
        • et al.
        Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer.
        N Engl J Med. 1999; 340: 1144-1153
        • Whitney C.W.
        • Sause W.
        • Bundy B.N.
        • et al.
        Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
        J Clin Oncol. 1999; 17: 1339-1348
        • Keys H.M.
        • Bundy B.N.
        • Stehman F.B.
        • et al.
        Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
        N Engl J Med. 1999; 340: 1154-1161
        • Blackledge G.
        • Buxton E.J.
        • Mould J.J.
        • et al.
        Phase II studies of ifosfamide alone and in combination in cancer of the cervix.
        Cancer Chemother Pharmacol. 1990; 26 (suppl): S12-S16
        • Buxton E.J.
        • Meanwell C.A.
        • Mould J.J.
        • et al.
        Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinoma.
        Acta Oncol. 1988; 27: 545-549
        • Buxton E.J.
        • Meanwell C.A.
        • Hilton C.
        • et al.
        Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
        J Natl Cancer Inst. 1989; 81: 359-361
        • Bonomi P.
        • Blessing J.A.
        • Stehman F.B.
        • DiSaia P.J.
        • Walton L.
        • Major F.J.
        Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
        J Clin Oncol. 1985; 3: 1079-1085
        • Omura G.A.
        • Blessing J.
        • Vaccarello L.
        • et al.
        A randomized trial of cisplatin (C) versus C + mitolactol (CM) versus C + ifosfamide (CIFX) in advanced squamous carcinoma of the cervix (SCC) by the Gynecologic Oncology Group (GOG) (Meeting abstract).
        in: Proc Annu Meet Am Soc Clin Oncol. 1995: 14
        • Kumar L.
        • Pokharel Y.H.
        • Kumar S.
        • Singh R.
        • Rath G.K.
        Kochupillai V Single agent versus combination chemotherapy in recurrent cervical cancer.
        J Obstet Gynaecol Res. 1998; 24: 401-409
        • Bezwoda W.R.
        • Nissenbaum M.
        • Derman D.P.
        Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro- platinum plus methotrexate.
        Med Pediatr Oncol. 1986; 14: 17-19
        • Park S.Y.
        • Kim J.H.
        • Kim B.G.
        • et al.
        Phase III randomized study of MVC intra-arterial (arm 1), or systemic (arm 2) neoadjuvant chemotherapy versus radiation therapy only (arm 3) for stage lIb bulky carcinoma of uterine cervix: preliminary report.
        in: 3rd edn. Proc Annu Meet Am Soc Clin Oncol. 1996: 15
        • Kigawa J.
        • Minagawa Y.
        • Ishihara H.
        • Itamochi H.
        • Kanamori Y.
        • Terakawa N.
        The role of neoadjuvant intra-arterial infusion chemotherapy with cisplatin and bleomycinc for locally advanced cervical cancer.
        Am J Clin Oncol. 1996; 19: 255-259
        • Morris M.
        • Gershenson D.M.
        • Burke T.W.
        • et al.
        A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
        Gynecol Oncol. 1994; 53: 234-238
        • McGuire W.P.
        • Blessing J.A.
        • Hatch K.
        • DiSaia P.J.
        A phase If study of CHIP in advanced squamous cell carcinoma of the cervix (a Gynecologic Oncology Group Study).
        Invest New Drugs. 1986; 4: 181-186
        • Lira-Puerto V.
        • Silva A.
        • Morris M.
        • et al.
        Phase II trial of carboplatin or iproplatin in cervical cancer.
        Cancer Chemother Pharmacol. 1991; 28: 391-396
        • Thigpen J.T.
        • Blessing J.A.
        • DiSaia P.J.
        • Fowler Jr., W.C.
        • Hatch K.D.
        A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
        Gynecol Oncol. 1989; 32: 198-202
        • Alberts D.S.
        • Kronmal R.
        • Baker L.H.
        • et al.
        Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
        J Clin Oncol. 1987; 5: 1791-1795
        • Weiss G.R.
        • Liu P.Y.
        • Alberts D.S.
        • Gandara D.R.
        • Baker L.H.
        • Hynes H.E.
        A randomized phase II trial of 13-cis-retinoic acid (CRA) or all-trans-retinoic acid (ATRA) plus interferon alpha 2a (IFN) for metastatic or recurrent squamous/adenosquamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
        in: Proc Annu Meet Am Soc Clin Oncol. 1997: 16
        • Omura G.A.
        • Velez-Garcia E.
        • Birch R.
        Phase II randomized study of doxorubicin, vincristine, and 5-FU versus cyclophosphamide in advanced squamous cell carcinoma of the cervix.
        Cancer Treat Rep. 1981; 65: 901-903
        • Edmonson J.H.
        • Johnson P.S.
        • Wieand H.S.
        • et al.
        Phase II studies of bleomycin, cyclophosphamide, doxorubicin and cisplatin, and bleomycin and cisplatin in advanced cervical carcinoma.
        Am J Clin Oncol. 1988; 11: 149-151
        • Weiss G.R.
        • Liu P.Y.
        • O'Sullivan J.
        • et al.
        A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial.
        Gynecol Oncol. 1992; 45: 303-306
        • Malkasian Jr., G.D.
        • Decker D.G.
        • Green S.J.
        • Edmonson J.H.
        • JefTeries J.A.
        • Webb M.J.
        Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracil.
        Gynecol Oncol. 1981; 11: 235-239

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0957-5847(99)90055-0

      Copyright

      © 1999 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX